Granules India informs about company updates

27 May 2019 Evaluate

Granules India has informed that Granules Pharmaceuticals, Inc. received US FDA approval for Methylphenidate Hydrochloride Extended-Release capsules.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

581.60 -17.80 (-2.97%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×